Open Label Study in Adolescents and Children With Myotonic Disorders

Summary

This is an open-label, multi-centre, single arm, interventional study to describe the steady-state PK, safety, and efficacy of mexiletine in paediatric patients (6 to \<18 years of age) with myotonic disorders.

Timeline

Start

2021-09-03

Primary completion

2024-06-14

Completion

2024-08-08

Drugs

Indications